| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |